Fosamax and osteonecrosis of the jaw--important questions and answers.
Wynn
Richard L
RL
D019386:Alendronate / Q000009:adverse effects* / Q000627:therapeutic use; D015519:Bone Density / Q000187:drug effects; D050071:Bone Density Conservation Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007571:Jaw Diseases / Q000139:chemically induced* / Q000150:complications / Q000517:prevention & control; D008334:Mandible / Q000187:drug effects; D008437:Maxilla / Q000187:drug effects; D010020:Osteonecrosis / Q000139:chemically induced* / Q000150:complications / Q000517:prevention & control; D010024:Osteoporosis / Q000628:therapy; D012307:Risk Factors
D050071:Bone Density Conservation Agents; D019386:Alendronate